InsiderTrades.com logo
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
From Crypto Swap Profits   |   Ad
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Register for the FREE Workshop Now & get $10 in Bitcoin

NVNO Insider Trading

Insider Ownership Percentage: 16.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $51,837.48

enVVeno Medical Insider Trading History Chart

This chart shows the insider buying and selling history at enVVeno Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

enVVeno Medical Share Price & Price History

Current Price: $2.49
Price Change: ▼ Price Decrease of -0.04 (-1.58%)
As of 12/20/2024 06:16 PM ET

This chart shows the closing price history over time for NVNO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Missed Nvidia? Buy Elon Musk’s “Silent Partner”
From Brownstone Research   |   Ad
In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.
So please click here to see the details because a lot of people could get rich.

enVVeno Medical Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/13/2024Hamed AlaviCTOSell8,334$6.22$51,837.48View SEC Filing Icon  
8/16/2022Francis DuhayDirectorBuy7,751$6.14$47,591.1420,911View SEC Filing Icon  
6/30/2022Sanjay ShrivastavaDirectorBuy1,000$3.85$3,850.003,888View SEC Filing Icon  
6/27/2022Robert Andrew BermanCEOBuy2,500$3.80$9,500.00210,236View SEC Filing Icon  
See Full Table
AI breakthrough about to upend industry
From Porter & Company   |   Ad
Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.
I urge you to watch it now.

SEC Filings (Institutional Ownership Changes) for enVVeno Medical (NASDAQ:NVNO)

34.71% of enVVeno Medical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NVNO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

enVVeno Medical Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/20/2024Westside Investment Management Inc.88,375$0.30M0.1%+128.0%0.504%Search for SEC Filing on Google Icon
11/19/2024Hohimer Wealth Management LLC85,000$0.29M0.1%N/A0.485%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC150,676$0.51M0.0%+7.8%0.859%Search for SEC Filing on Google Icon
11/15/2024Maven Securities LTD87,880$0.30M0.0%N/A0.501%Search for SEC Filing on Google Icon
11/14/2024Corsair Capital Management L.P.116,000$0.39M0.1%N/A0.661%Search for SEC Filing on Google Icon
8/20/2024Nantahala Capital Management LLC477,855$2.51M0.1%-3.6%3.585%Search for SEC Filing on Google Icon
7/17/2024Westside Investment Management Inc.38,762$0.20M0.0%+933.7%0.291%Search for SEC Filing on Google Icon
7/13/2024Fermata Advisors LLC30,949$0.16M0.0%+33.4%0.232%Search for SEC Filing on Google Icon
5/16/2024Kingdon Capital Management L.L.C.653,870$3.56M0.4%+5.6%4.905%Search for SEC Filing on Google Icon
5/15/2024Quadrature Capital Ltd18,872$0.10M0.0%N/A0.142%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC6,825$37K0.0%N/A0.051%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.573,955$3.12M0.0%+70.6%4.310%Search for SEC Filing on Google Icon
5/3/2024RIA Advisory Group LLC43,666$0.24M0.1%N/A0.328%Search for SEC Filing on Google Icon
5/1/2024Janney Montgomery Scott LLC34,140$0.19M0.0%N/A0.256%Search for SEC Filing on Google Icon
4/12/2024Fermata Advisors LLC23,198$0.13M0.0%+42.1%0.174%Search for SEC Filing on Google Icon
3/18/2024Kingdon Capital Management L.L.C.619,180$3.18M0.4%+182.5%4.648%Search for SEC Filing on Google Icon
2/26/2024Perceptive Advisors LLC623,315$3.20M0.1%-20.3%4.680%Search for SEC Filing on Google Icon
2/13/2024Armistice Capital LLC436,000$2.24M0.0%N/A3.273%Search for SEC Filing on Google Icon
1/19/2024Fermata Advisors LLC16,325$84K0.0%+37.8%0.123%Search for SEC Filing on Google Icon
11/7/2023Fermata Advisors LLC11,850$64K0.0%N/A0.089%Search for SEC Filing on Google Icon
7/19/2023Arthur M. Cohen & Associates LLC14,000$43K0.0%-41.7%0.148%Search for SEC Filing on Google Icon
11/14/2022UBS Oconnor LLC149,720$0.94M0.0%+26.8%1.581%Search for SEC Filing on Google Icon
7/26/2022Sepio Capital LP10,800$41K0.0%N/A0.114%Search for SEC Filing on Google Icon
7/18/2022Arthur M. Cohen & Associates LLC24,000$91K0.0%+60.0%0.253%Search for SEC Filing on Google Icon
5/11/2022ACT Capital Management LLC401,200$2.56M2.7%+52.8%4.237%Search for SEC Filing on Google Icon
2/15/2022Kingdon Capital Management L.L.C.219,180$1.44M0.2%N/A2.315%Search for SEC Filing on Google Icon
2/14/2022Perceptive Advisors LLC781,615$5.15M0.1%N/A8.255%Search for SEC Filing on Google Icon
2/3/2022ACT Capital Management LLC262,500$1.73M1.3%N/A2.772%Search for SEC Filing on Google Icon
1/24/2022Arthur M. Cohen & Associates LLC14,000$92K0.0%N/A0.148%Search for SEC Filing on Google Icon
8/17/2021Worth Venture Partners LLC82,886$0.57M0.2%-17.7%0.974%Search for SEC Filing on Google Icon
8/16/2021State Street Corp20,200$0.14M0.0%N/A0.237%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC63,753$0.44M0.0%+75.8%0.749%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.258,680$1.78M0.0%+483.6%3.038%Search for SEC Filing on Google Icon
8/12/2021AIGH Capital Management LLC346,885$2.38M0.4%-19.1%4.074%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC11,512$77K0.0%N/A0.135%Search for SEC Filing on Google Icon
5/19/2021Worth Venture Partners LLC100,714$0.67M0.3%N/A1.183%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC23,567$0.16M0.0%N/A0.277%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC11,512$77K0.0%N/A0.135%Search for SEC Filing on Google Icon
5/18/2021Jane Street Group LLC21,745$0.15M0.0%N/A0.255%Search for SEC Filing on Google Icon
5/14/2021Dimensional Fund Advisors LP10,821$72K0.0%N/A0.127%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp15,360$0.10M0.0%N/A0.181%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC36,268$0.24M0.0%N/A0.426%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG17,061$0.11M0.0%+1,326.5%0.201%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC26,107$0.23M0.0%N/A1.008%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
enVVeno Medical logo
enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company's lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI). Deep venous CVI occurs when valves inside of the deep veins of the leg become damaged, resulting in insufficient blood being returned to the heart. The malfunctioning vein valves cause blood to flow backwards (reflux) and pool in the lower leg, increasing the pressure within the veins of the leg (venous hypertension). In the most severe cases, CVI can lead to venous ulcers (open skin sores) that become chronic and difficult to heal. The VenoValve is implanted in the femoral vein and works as a replacement venous valve, designed to reduce reflux and venous hypertension, and to restore proper directional blood flow back to the heart. With severe deep venous CVI impacting an estimated 2.4 million people in the U.S., who have no effective treatment options, the VenoValve has received Breakthrough Device Designation from the U.S. Food and Drug Administration, and is currently being evaluated in the SAVVE U.S. clinical trial.
Read More on enVVeno Medical

Today's Range

Now: $2.49
Low: $2.45
High: $2.74

50 Day Range

MA: $3.22
Low: $2.49
High: $3.65

52 Week Range

Now: $2.49
Low: $2.45
High: $6.97

Volume

691,785 shs

Average Volume

112,245 shs

Market Capitalization

$43.66 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.22

Who are the company insiders with the largest holdings of enVVeno Medical?

enVVeno Medical's top insider investors include:
  1. Hamed Alavi (CTO)
Learn More about top insider investors at enVVeno Medical.

Who are the major institutional investors of enVVeno Medical?

enVVeno Medical's top institutional investors include:
  1. Geode Capital Management LLC — 0.86%
  2. Corsair Capital Management L.P. — 0.66%
  3. Westside Investment Management Inc. — 0.50%
  4. Maven Securities LTD — 0.50%
  5. Hohimer Wealth Management LLC — 0.48%
Learn More about top institutional investors of enVVeno Medical stock.

Which institutional investors are buying enVVeno Medical stock?

During the last quarter, NVNO stock was purchased by institutional investors including:
  1. Corsair Capital Management L.P.
  2. Maven Securities LTD
  3. Hohimer Wealth Management LLC
  4. Westside Investment Management Inc.
  5. Geode Capital Management LLC
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
From Crypto Swap Profits   |   Ad
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Register for the FREE Workshop Now & get $10 in Bitcoin